Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma.

Cancers (Basel) · 2019 · PMC6678132 · PMID 31319594

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Second, patients who received a greater number of overall therapies showed a trend toward longer OS, as did those patients who received a greater number of clinically beneficial therapies.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.